Implanon Nxt

Etonogestrel, the active ingredient in Implanon Nxt, is a progestin presented as a 68 mg subdermal implant for subcutaneous use. It prevents pregnancy in women of reproductive age.

GNH USA supplies Implanon Nxt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Etonogestrel, a progestin contraceptive, is indicated for prevention of pregnancy.

- Contraception: provides long‑acting reversible birth control for up to three years. - Family planning: enables women to avoid unintended pregnancy without daily dosing. - Prevention of pregnancy: offers a single‑procedure method with high efficacy.

Common Side Effects: - Irregular vaginal bleeding or amenorrhea. - Headache. - Acne or oily skin. - Weight gain. - Insertion‑site pain or bruising. - Mood changes.

Serious or Rare Side Effects: - Infection at the implant site. - Deep vein thrombosis or pulmonary embolism. - Severe allergic reaction (anaphylaxis). - Ectopic pregnancy if contraceptive failure occurs. - Implant migration or extrusion.

Before using Implanon Nxt, consider the following precautions.

- Medical evaluation: confirm no contraindications such as active thromboembolic disorders. - Medication review: assess for drugs that may reduce contraceptive effectiveness. - Pregnancy testing: ensure the patient is not pregnant prior to insertion. - Follow‑up: schedule a post‑insertion visit to verify proper placement. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Etonogestrel may interact with other medicines; review the following.

Major Interactions (Avoid): - Rifampin: enzyme inducer that can lower etonogestrel levels. - Carbamazepine: may reduce contraceptive efficacy. - Phenytoin: can decrease hormone concentrations. - St. John’s wort: herbal inducer that may compromise effectiveness. - Anticonvulsants (e.g., phenobarbital): risk of reduced protection.

Moderate Interactions (Monitor Closely): - Azole antifungals (e.g., ketoconazole): may increase hormone levels. - HIV protease inhibitors: potential elevation of etonogestrel concentrations.